Private Equity Portfolio Company
EffRx
S/Lausanne
Switzerland
https://www.effrx.com
EffRx has an exclusive world-wide license from Merck & Co to an effervescent form of FOSAMAX, Merck's $1 billion+ osteoporosis drug. Many patients cannot take Merck's form of FOSAMAX and hence EffRx's more tolerable version can command a si...
Private Equity Owner: NMT Capital (Nexus)
Acquisition Criteria
Investment Date:
Exit Date:
Status:
Add-on Acquisitions:
Industry (NAICS Code):
Testimonials
Become the next customer to share a success story about Private Equity Info's impact.
"Private Equity Info is critical to nearly every aspect of our role as an investment bank. We use it almost every day and the return on investment is clear."
Bob McCormack
"PEI is superior for our sales team. It cuts to the core. It’s the sweet spot in terms of what you’re paying and what you’re getting.”
